William Jacob Savage - 13 Apr 2026 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Reporting relationship: Chief Medical Officer
Issuer ticker: IRON
Reported as of: 13 Apr 2026
Net transaction value: -$380,449
SEC form: 4
Accepted by SEC: 15 Apr 2026, 17:05:27 UTC
Prior SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Rahul Khara, as Attorney-in-Fact

Key filing fact

William Jacob Savage filed Form 4 for Disc Medicine, Inc. (IRON) on 15 Apr 2026.

Key facts

This page summarizes William Jacob Savage's Form 4 filing for Disc Medicine, Inc. (IRON).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 Apr 2026, 17:05.

Change

Previous filing in this sequence was filed on 04 Mar 2026.
Current net transaction value: -$380,449.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001951852 Primary reporting owner

Savage William Jacob

Relationship: Chief Medical Officer
Address: C/O DISC MEDICINE, INC., 321 ARSENAL STREET, SUITE 101, WATERTOWN
Signature: By: /s/ Rahul Khara, as Attorney-in-Fact
Signature date: 15 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRON transaction

Common Stock

Sale

Transaction value: $233,473
Shares: -3,531
Change %: -4.1%
Price: $66.12
Shares after: 81,680
Date: 13 Apr 2026
Ownership: Direct
Footnotes: F1, F2

IRON transaction

Common Stock

Sale

Transaction value: $146,976
Shares: -2,200
Change %: -2.7%
Price: $66.81
Shares after: 79,480
Date: 13 Apr 2026
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive.